ibs glp 1 Semaglutide, GLP-1 Drugs, and IBS: Managing Side Effects and Gut Health GLP-1 Series | Part 4

Lose at a sensible pace

When the nutrients subsequently reach the distal gut, direct contact with the L-cells then triggers additional GLP-1 secretion into the circulation (as also reviewed in [320])

Additionally, these medications slow down gastric emptying, making me feel fuller for longer

However, evidence on the cardiovascular benefits of tirzepatide is only emerging and no randomized study has directly compared it to semaglutide 16,17

At this time, it is uncertain how participating beneficiaries will be able to maintain Medicare coverage of their GLP-1 medication for obesity after the Medicare GLP-1 Bridge ends at the end of 2027, pending further action from CMS to implement the BALANCE Model in Medicare Part D in 2028, as described below

Some insurance plans cover Wegovy for weight loss, while others only cover it for cardiovascular risk reduction or liver disease treatment